ARI-0001

DRUG2 trials

Sponsors

Universitair Medisch Centrum Groningen, University Medical Center Groningen

Conditions

DLBCL - Diffuse Large B Cell LymphomaNHLrelapsed/refractory Non-Hodgkin Lymphoma

Phase 2

Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL

Active, not recruitingNCT05641428

University Medical Center GroningenNHL, DLBCL - Diffuse Large B Cell Lymphoma

Start: 2022-10-18End: 2028-09-01Updated: 2026-10-05

HOVON 161: A phase II non-inferiority study comparing point-of-care produced CAR T-cell to commercial CAR T-cells in patients with relapsed/refractory Non-Hodgkin Lymphoma

RecruitingCTIS2024-511979-15-00

Universitair Medisch Centrum Groningenrelapsed/refractory Non-Hodgkin Lymphoma

Start: 2022-10-14Target: 340Updated: 2025-05-22